LifeVantage Corporation — Form 10-Q Summary
Business context and reporting period. LifeVantage sells dietary supplements, wellness, personal-care and related products through customers and independent distributors across international markets. This unaudited report covers the quarter and six months ended December 31, 2020 (the second quarter of fiscal 2021); comparisons are with the corresponding 2019 periods.
Key financial results
| Metric | Quarter ended Dec. 31, 2020 | Quarter ended Dec. 31, 2019 | Six months ended Dec. 31, 2020 | Six months ended Dec. 31, 2019 |
|---|---|---|---|---|
| Revenue | $59.0 million | $61.2 million | $113.8 million | $117.5 million |
| Gross profit / margin | $48.8 million / 82.7% | $51.0 million / 83.3% | $94.2 million / 82.8% | $98.0 million / 83.5% |
| Operating income | $5.4 million | $3.6 million | $8.9 million | $6.2 million |
| Net income | $3.8 million | $4.3 million | $6.3 million | $6.1 million |
| Diluted earnings per share | $0.26 | $0.30 | $0.43 | $0.42 |
| Operating cash flow | Not separately stated | Not separately stated | $4.8 million | $5.8 million |
Quarterly revenue declined about 3.6%, while six-month revenue declined about 3.1%. Operating income improved in both comparisons as commissions and selling, general and administrative expenses fell. Quarterly net income declined despite higher operating income, mainly reflecting the shift from a prior-year income tax benefit to current-year tax expense. The six-month effective tax rate was 29.8%, versus (2.7)% in the prior-year period.
- Cash and liquidity: Cash was $19.7 million at December 31, down $2.4 million from June 30, 2020. Six-month working capital was $20.0 million, compared with $18.8 million at June 30. Management said cash and expected operating cash flow should meet requirements for at least 12 months.
- Cash flows: Six-month operating cash flow was $4.8 million; investing cash outflow was $1.5 million, primarily for property and equipment; financing cash outflow was $5.9 million, principally for share repurchases and tax withholding on equity awards.
- Debt and leases: The company reported that its term loan was repaid in full during fiscal 2020 and reported no term-loan interest in the current periods. A revolving facility of up to $5.0 million remains available; the filing does not clearly state whether any amount was drawn. Operating lease liabilities totaled $17.5 million at December 31.
- Capital returns: The company repurchased approximately 0.5 million shares for $6.0 million during the six months. About $17.4 million remained under the $35 million repurchase authorization.
Material changes and operating trends
- Americas revenue fell 5.4% in the quarter and 4.6% for six months. Management attributed the decline to fewer active accounts and the prior-year comparison benefiting from the October 2019 launch of Protandim NAD Synergizer. Active accounts in the Americas were down 5.9% year over year.
- Asia/Pacific & Europe revenue rose 1.0% in the quarter and 0.8% for six months, with currency contributing positively. Japan grew 5.9% quarterly, while Greater China declined 19.8%. Total active accounts fell 4.4% globally, including a 6.1% decline in active customers.
- Gross margin eased year over year, which management attributed to higher customer shipping costs, reduced event-fee revenue and changes in geographic and product mix.
- Commissions and incentives declined as a share of revenue to 46.0% for the quarter and 46.4% for six months, partly because COVID-19 restrictions limited events and incentive programs. SG&A also declined, reflecting lower event and travel costs and some compensation changes.
Outlook, risks, contingencies and unusual items
- Outlook: No quantitative revenue or earnings guidance was provided. Management described fiscal 2021 priorities including subscription and loyalty programs, distributor support and training, product and market development, and strengthening systems. It expected commissions and SG&A as a percentage of revenue to fluctuate as plans adapt to the pandemic.
- COVID-19: The company reported remote work, closures of some international showrooms and will-call locations, and canceled events. Management cited ongoing uncertainty around distributor recruiting, supply, shipping and customer purchasing, and said it was monitoring costs, liquidity and operations.
- Unusual expense: Abandonment of the former Sandy, Utah corporate office lease and related leasehold assets resulted in a $0.8 million expense during the six months. A new Lehi, Utah office opened in January 2021; employees remained remote at the filing date.
- Litigation: A purported class action alleging securities-law violations remains pending. The court dismissed certain claims, while allowing a Section 12(2) claim to proceed. The company recorded no loss accrual, stating liability was not probable or estimable, but warned an unfavorable outcome could materially affect results or financial condition.
- Other risks: Foreign exchange, reliance on independent distributors and a limited product portfolio, regulatory and product-liability exposure, supply-chain disruption, and restrictive credit-facility covenants are among the disclosed risks. The company was in compliance with its credit covenants at quarter-end. A 10% strengthening of the U.S. dollar was estimated to reduce six-month revenue by $3.5 million.
Important facts for investors to verify
- Whether active customer and distributor counts stabilize, particularly in the Americas, and whether revenue growth can be sustained without favorable currency effects.
- Whether cost reductions and lower event spending are temporary, and how investment in promotions and distributor programs affects future margins.
- The amount, if any, drawn on the $5.0 million revolving credit facility and the company’s continued compliance with its covenants.
- Developments in the securities class action and any potential financial exposure.
- The impact of office-lease changes, ongoing COVID-19 disruptions, and inventory obsolescence or returns on future cash flow.